Received Aug 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | LG749 | IM / LA |
Patient presented to clinic for second dose of Hepatitis B vaccine series. Upon retrieving vaccine and confirming patient identity (name and DOB), RN identified discrepancy between patient's age (18 years) and vaccine order, which had been entered for patients aged 20 and older. RN promptly contacted ordering provider and requested correction of vaccine order to reflect appropriate dosing for 18-year-old. Correct vaccine and dose were obtained, verified, and administered; documentation was completed accurately. During post-vaccination documentation review, it was noted patient had previously received adult Hepatitis B dose (intended for patients 20 years and older) as first dose, rather than pediatric dose appropriate for age at that time. RN reported this to supervisor, and in absence of medical director, situation was escalated to clinic manager. Based on CDC guidelines, team determined to hold third scheduled dose and obtain Hepatitis B surface antibody titers. Agency was consulted for further guidance. As of today, response was received from agency advising patient should proceed with receiving third pediatric dose as originally scheduled. Patient has been notified accordingly.
none
none
none
none
none